All articles by lroy

Breakthrough Device status granted for Dthera’s Alzheimer’s treatment

The US Food and Drug Administration (FDA) has granted Breakthrough Device designation to digital therapeutic company Dthera Sciences for its development-stage product DTHR-ALZ.